Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors

N/AWithdrawnNCT02074254

Ohio State University

Overview

We propose a retrospective review of our experience with bleeding complication in the presence of antiplatelet and SSRI therapy and compare the complications with those who were not on antiplatelet agents or SSRI.

Study Type

OBSERVATIONAL

Conditions

Tracheostomy Complication

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * on antiplatelet therapy or selective serotonin reuptake inhibitors(SSRI) Exclusion Criteria: * N/A

Locations (2)

OSUMC

Columbus, Ohio, United States

University Hospital, OSUMC 473 W 12th Ave

Columbus, Ohio, United States

Outcomes

Primary Outcomes

a retrospective review of our experience with bleeding complication in the presence of antiplatelet and SSRI therapy and compare the complications with those who were not on antiplatelet agents or SSRI

Time frame: 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.